Pacific Sun Financial Corp Has $784,000 Holdings in VanEck Biotech ETF (NASDAQ:BBH)

Pacific Sun Financial Corp decreased its position in shares of VanEck Biotech ETF (NASDAQ:BBH) by 11.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,993 shares of the company’s stock after selling 674 shares during the quarter. Pacific Sun Financial Corp’s holdings in VanEck Biotech ETF were worth $784,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Truvestments Capital LLC bought a new stake in VanEck Biotech ETF during the 3rd quarter valued at $44,000. FSA Wealth Management LLC bought a new position in shares of VanEck Biotech ETF in the third quarter valued at $54,000. Coastline Trust Co acquired a new position in shares of VanEck Biotech ETF during the third quarter valued at about $59,000. Wilmington Savings Fund Society FSB bought a new stake in shares of VanEck Biotech ETF during the third quarter worth about $166,000. Finally, Tyler Stone Wealth Management increased its position in shares of VanEck Biotech ETF by 79.5% during the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock worth $261,000 after acquiring an additional 652 shares in the last quarter. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Stock Up 1.4 %

Shares of NASDAQ BBH opened at $163.55 on Thursday. VanEck Biotech ETF has a fifty-two week low of $151.35 and a fifty-two week high of $183.64. The firm’s 50-day simple moving average is $161.10 and its 200 day simple moving average is $169.49.

VanEck Biotech ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Tuesday, December 24th. Stockholders of record on Monday, December 23rd were issued a $1.2517 dividend. The ex-dividend date was Monday, December 23rd.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.